View Future GrowthNorofert 과거 순이익 실적과거 기준 점검 4/6Norofert의 수입은 연평균 -13%의 비율로 감소해 온 반면, Chemicals 산업은 수입이 연평균 25% 감소했습니다. 매출은 연평균 2.7%의 비율로 증가해 왔습니다. Norofert의 자기자본이익률은 13.7%이고 순이익률은 8.3%입니다.핵심 정보-13.01%순이익 성장률n/a주당순이익(EPS) 성장률Chemicals 산업 성장률39.70%매출 성장률2.67%자기자본이익률13.70%순이익률8.26%최근 순이익 업데이트31 Dec 2025최근 과거 실적 업데이트Reported Earnings • Nov 27Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: RON14.5m (down 4.7% from 3Q 2024). Net income: RON1.38m (up RON1.85m from 3Q 2024). Profit margin: 9.5% (up from net loss in 3Q 2024). The move to profitability was driven by lower expenses.Reported Earnings • Sep 26Second quarter 2025 earnings releasedSecond quarter 2025 results: Revenue: RON7.17m (down 36% from 2Q 2024). Net loss: RON4.59m (down 348% from profit in 2Q 2024).Reported Earnings • May 29First quarter 2025 earnings releasedFirst quarter 2025 results: Revenue: RON14.0m (up 20% from 1Q 2024). Net income: RON5.35m (up RON5.34m from 1Q 2024). Profit margin: 38% (up from 0% in 1Q 2024). The increase in margin was primarily driven by lower expenses.Reported Earnings • Apr 14Full year 2024 earnings released: EPS: RON0.19 (vs RON0.23 loss in FY 2023)Full year 2024 results: EPS: RON0.19 (up from RON0.23 loss in FY 2023). Revenue: RON52.6m (up 19% from FY 2023). Net income: RON3.24m (up RON7.19m from FY 2023). Profit margin: 6.2% (up from net loss in FY 2023). The move to profitability was driven by higher revenue.Reported Earnings • Dec 01Third quarter 2024 earnings releasedThird quarter 2024 results: Revenue: RON15.3m (up 11% from 3Q 2023). Net loss: RON473.8k (loss narrowed 76% from 3Q 2023).Reported Earnings • Oct 03Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: RON11.2m (up 30% from 2Q 2023). Net income: RON1.85m (up 29% from 2Q 2023). Profit margin: 17% (in line with 2Q 2023).모든 업데이트 보기Recent updates공지 • Mar 24Norofert S.A., Annual General Meeting, Apr 29, 2026Norofert S.A., Annual General Meeting, Apr 29, 2026.공지 • Feb 25Norofert S.A. (BVB:NRF) agreed to acquire 60% stake in Expert Agribusiness Srl on February 23, 2026.Norofert S.A. (BVB:NRF) entered into an agreement to acquire 60% stake in Expert Agribusiness Srl on February 23, 2026. The transaction amounted to €0.1 million. The full amount will be paid by December 2026.분석 기사 • Jan 17Norofert S.A.'s (BVB:NRF) Business Is Trailing The Industry But Its Shares Aren'tWith a median price-to-sales (or "P/S") ratio of close to 1.4x in the Chemicals industry in Romania, you could be...분석 기사 • Dec 03Some Investors May Be Worried About Norofert's (BVB:NRF) Returns On CapitalIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a...Reported Earnings • Nov 27Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: RON14.5m (down 4.7% from 3Q 2024). Net income: RON1.38m (up RON1.85m from 3Q 2024). Profit margin: 9.5% (up from net loss in 3Q 2024). The move to profitability was driven by lower expenses.Reported Earnings • Sep 26Second quarter 2025 earnings releasedSecond quarter 2025 results: Revenue: RON7.17m (down 36% from 2Q 2024). Net loss: RON4.59m (down 348% from profit in 2Q 2024).Valuation Update With 7 Day Price Move • Jul 16Investor sentiment improves as stock rises 17%After last week's 17% share price gain to RON3.94, the stock trades at a trailing P/E ratio of 8x. Average trailing P/E is 21x in the Chemicals industry in Europe. Negligible returns to shareholders over past year.분석 기사 • Jul 15Here's Why Norofert (BVB:NRF) Has A Meaningful Debt BurdenDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Reported Earnings • May 29First quarter 2025 earnings releasedFirst quarter 2025 results: Revenue: RON14.0m (up 20% from 1Q 2024). Net income: RON5.35m (up RON5.34m from 1Q 2024). Profit margin: 38% (up from 0% in 1Q 2024). The increase in margin was primarily driven by lower expenses.분석 기사 • May 24Optimistic Investors Push Norofert S.A. (BVB:NRF) Shares Up 28% But Growth Is LackingNorofert S.A. ( BVB:NRF ) shareholders have had their patience rewarded with a 28% share price jump in the last month...Valuation Update With 7 Day Price Move • May 23Investor sentiment improves as stock rises 28%After last week's 28% share price gain to RON3.69, the stock trades at a trailing P/E ratio of 19.8x. Average trailing P/E is 18x in the Chemicals industry in Europe. Total loss to shareholders of 13% over the past year.분석 기사 • May 17There Are Reasons To Feel Uneasy About Norofert's (BVB:NRF) Returns On CapitalIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...New Risk • May 10New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: RON45.4m (US$9.98m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.1x net interest cover). Earnings have declined by 26% per year over the past 5 years. Market cap is less than US$10m (RON45.4m market cap, or US$9.98m).New Risk • Apr 23New major risk - Revenue and earnings growthEarnings have declined by 26% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.1x net interest cover). Earnings have declined by 26% per year over the past 5 years. Minor Risk Market cap is less than US$100m (RON48.5m market cap, or US$11.1m).New Risk • Apr 22New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 0% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (0% operating cash flow to total debt). Minor Risk Market cap is less than US$100m (RON48.5m market cap, or US$11.1m).Reported Earnings • Apr 14Full year 2024 earnings released: EPS: RON0.19 (vs RON0.23 loss in FY 2023)Full year 2024 results: EPS: RON0.19 (up from RON0.23 loss in FY 2023). Revenue: RON52.6m (up 19% from FY 2023). Net income: RON3.24m (up RON7.19m from FY 2023). Profit margin: 6.2% (up from net loss in FY 2023). The move to profitability was driven by higher revenue.분석 기사 • Apr 01Norofert S.A.'s (BVB:NRF) Price In Tune With RevenuesIt's not a stretch to say that Norofert S.A.'s ( BVB:NRF ) price-to-sales (or "P/S") ratio of 1.2x seems quite...공지 • Mar 31Norofert S.A., Annual General Meeting, May 05, 2025Norofert S.A., Annual General Meeting, May 05, 2025.Reported Earnings • Dec 01Third quarter 2024 earnings releasedThird quarter 2024 results: Revenue: RON15.3m (up 11% from 3Q 2023). Net loss: RON473.8k (loss narrowed 76% from 3Q 2023).Reported Earnings • Oct 03Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: RON11.2m (up 30% from 2Q 2023). Net income: RON1.85m (up 29% from 2Q 2023). Profit margin: 17% (in line with 2Q 2023).분석 기사 • Sep 19Is Norofert (BVB:NRF) Using Too Much Debt?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Reported Earnings • Jun 04First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: RON11.7m (down 14% from 1Q 2023). Net income: RON1.4k (down 100% from 1Q 2023). Profit margin: 0% (down from 12% in 1Q 2023). The decrease in margin was driven by lower revenue.Board Change • May 02No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. No independent directors (3 non-independent directors). Non-Executive Director Marian Alexe was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.매출 및 비용 세부 내역Norofert가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이BVB:NRF 매출, 비용 및 순이익 (RON Millions)날짜매출순이익일반관리비연구개발비31 Dec 254545030 Sep 254465030 Jun 254855031 Mar 255395031 Dec 245035030 Sep 2444-47030 Jun 2443-57031 Mar 2442-67031 Dec 2344-47030 Sep 235344030 Jun 236585031 Mar 2371105031 Dec 2273115030 Sep 2276106030 Jun 226485031 Mar 2264105031 Dec 215375030 Sep 213834030 Jun 213154031 Mar 212314031 Dec 202544030 Sep 203094030 Jun 202784031 Mar 202163031 Dec 191552031 Dec 1810410양질의 수익: NRF는 고품질 수익을 보유하고 있습니다.이익 마진 증가: NRF의 현재 순 이익률 (8.3%)은 지난해 (6.4%)보다 높습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: NRF의 수익은 지난 5년 동안 연평균 13% 감소했습니다.성장 가속화: 지난 1년간 NRF 의 수익 증가율(15.7%)은 연간 평균(-13%)을 초과합니다.수익 대 산업: NRF의 지난 1년 수익 증가율(15.7%)은 Chemicals 업계의 -1.3%를 상회했습니다.자기자본이익률높은 ROE: NRF의 자본 수익률(13.7%)은 낮음으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/07 11:11종가2026/05/07 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Norofert S.A.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Reported Earnings • Nov 27Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: RON14.5m (down 4.7% from 3Q 2024). Net income: RON1.38m (up RON1.85m from 3Q 2024). Profit margin: 9.5% (up from net loss in 3Q 2024). The move to profitability was driven by lower expenses.
Reported Earnings • Sep 26Second quarter 2025 earnings releasedSecond quarter 2025 results: Revenue: RON7.17m (down 36% from 2Q 2024). Net loss: RON4.59m (down 348% from profit in 2Q 2024).
Reported Earnings • May 29First quarter 2025 earnings releasedFirst quarter 2025 results: Revenue: RON14.0m (up 20% from 1Q 2024). Net income: RON5.35m (up RON5.34m from 1Q 2024). Profit margin: 38% (up from 0% in 1Q 2024). The increase in margin was primarily driven by lower expenses.
Reported Earnings • Apr 14Full year 2024 earnings released: EPS: RON0.19 (vs RON0.23 loss in FY 2023)Full year 2024 results: EPS: RON0.19 (up from RON0.23 loss in FY 2023). Revenue: RON52.6m (up 19% from FY 2023). Net income: RON3.24m (up RON7.19m from FY 2023). Profit margin: 6.2% (up from net loss in FY 2023). The move to profitability was driven by higher revenue.
Reported Earnings • Dec 01Third quarter 2024 earnings releasedThird quarter 2024 results: Revenue: RON15.3m (up 11% from 3Q 2023). Net loss: RON473.8k (loss narrowed 76% from 3Q 2023).
Reported Earnings • Oct 03Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: RON11.2m (up 30% from 2Q 2023). Net income: RON1.85m (up 29% from 2Q 2023). Profit margin: 17% (in line with 2Q 2023).
공지 • Mar 24Norofert S.A., Annual General Meeting, Apr 29, 2026Norofert S.A., Annual General Meeting, Apr 29, 2026.
공지 • Feb 25Norofert S.A. (BVB:NRF) agreed to acquire 60% stake in Expert Agribusiness Srl on February 23, 2026.Norofert S.A. (BVB:NRF) entered into an agreement to acquire 60% stake in Expert Agribusiness Srl on February 23, 2026. The transaction amounted to €0.1 million. The full amount will be paid by December 2026.
분석 기사 • Jan 17Norofert S.A.'s (BVB:NRF) Business Is Trailing The Industry But Its Shares Aren'tWith a median price-to-sales (or "P/S") ratio of close to 1.4x in the Chemicals industry in Romania, you could be...
분석 기사 • Dec 03Some Investors May Be Worried About Norofert's (BVB:NRF) Returns On CapitalIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a...
Reported Earnings • Nov 27Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: RON14.5m (down 4.7% from 3Q 2024). Net income: RON1.38m (up RON1.85m from 3Q 2024). Profit margin: 9.5% (up from net loss in 3Q 2024). The move to profitability was driven by lower expenses.
Reported Earnings • Sep 26Second quarter 2025 earnings releasedSecond quarter 2025 results: Revenue: RON7.17m (down 36% from 2Q 2024). Net loss: RON4.59m (down 348% from profit in 2Q 2024).
Valuation Update With 7 Day Price Move • Jul 16Investor sentiment improves as stock rises 17%After last week's 17% share price gain to RON3.94, the stock trades at a trailing P/E ratio of 8x. Average trailing P/E is 21x in the Chemicals industry in Europe. Negligible returns to shareholders over past year.
분석 기사 • Jul 15Here's Why Norofert (BVB:NRF) Has A Meaningful Debt BurdenDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Reported Earnings • May 29First quarter 2025 earnings releasedFirst quarter 2025 results: Revenue: RON14.0m (up 20% from 1Q 2024). Net income: RON5.35m (up RON5.34m from 1Q 2024). Profit margin: 38% (up from 0% in 1Q 2024). The increase in margin was primarily driven by lower expenses.
분석 기사 • May 24Optimistic Investors Push Norofert S.A. (BVB:NRF) Shares Up 28% But Growth Is LackingNorofert S.A. ( BVB:NRF ) shareholders have had their patience rewarded with a 28% share price jump in the last month...
Valuation Update With 7 Day Price Move • May 23Investor sentiment improves as stock rises 28%After last week's 28% share price gain to RON3.69, the stock trades at a trailing P/E ratio of 19.8x. Average trailing P/E is 18x in the Chemicals industry in Europe. Total loss to shareholders of 13% over the past year.
분석 기사 • May 17There Are Reasons To Feel Uneasy About Norofert's (BVB:NRF) Returns On CapitalIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...
New Risk • May 10New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: RON45.4m (US$9.98m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.1x net interest cover). Earnings have declined by 26% per year over the past 5 years. Market cap is less than US$10m (RON45.4m market cap, or US$9.98m).
New Risk • Apr 23New major risk - Revenue and earnings growthEarnings have declined by 26% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.1x net interest cover). Earnings have declined by 26% per year over the past 5 years. Minor Risk Market cap is less than US$100m (RON48.5m market cap, or US$11.1m).
New Risk • Apr 22New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 0% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (0% operating cash flow to total debt). Minor Risk Market cap is less than US$100m (RON48.5m market cap, or US$11.1m).
Reported Earnings • Apr 14Full year 2024 earnings released: EPS: RON0.19 (vs RON0.23 loss in FY 2023)Full year 2024 results: EPS: RON0.19 (up from RON0.23 loss in FY 2023). Revenue: RON52.6m (up 19% from FY 2023). Net income: RON3.24m (up RON7.19m from FY 2023). Profit margin: 6.2% (up from net loss in FY 2023). The move to profitability was driven by higher revenue.
분석 기사 • Apr 01Norofert S.A.'s (BVB:NRF) Price In Tune With RevenuesIt's not a stretch to say that Norofert S.A.'s ( BVB:NRF ) price-to-sales (or "P/S") ratio of 1.2x seems quite...
공지 • Mar 31Norofert S.A., Annual General Meeting, May 05, 2025Norofert S.A., Annual General Meeting, May 05, 2025.
Reported Earnings • Dec 01Third quarter 2024 earnings releasedThird quarter 2024 results: Revenue: RON15.3m (up 11% from 3Q 2023). Net loss: RON473.8k (loss narrowed 76% from 3Q 2023).
Reported Earnings • Oct 03Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: RON11.2m (up 30% from 2Q 2023). Net income: RON1.85m (up 29% from 2Q 2023). Profit margin: 17% (in line with 2Q 2023).
분석 기사 • Sep 19Is Norofert (BVB:NRF) Using Too Much Debt?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Reported Earnings • Jun 04First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: RON11.7m (down 14% from 1Q 2023). Net income: RON1.4k (down 100% from 1Q 2023). Profit margin: 0% (down from 12% in 1Q 2023). The decrease in margin was driven by lower revenue.
Board Change • May 02No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. No independent directors (3 non-independent directors). Non-Executive Director Marian Alexe was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.